J

John Pepper

Harefield Hospital

Publishes on Cardiac Valve Diseases and Treatments, Aortic Disease and Treatment Approaches, Cardiovascular Function and Risk Factors. 354 papers and 13.8k citations.

354Publications
13.8kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Guidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Alec Vahanian, Ottavio Alfieri et al.|European Heart Journal|2012
Cited by 3.6kOpen Access

The ESC/EACTS Guidelines represent the views of the ESC and the EACTS and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, however, override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient and, where appropriate and necessary, the patient's guardian or carer. It is also the health professional's responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.

A Randomized Comparison of Off-Pump and On-Pump Multivessel Coronary-Artery Bypass Surgery
Natasha Khan, Anthony De Souza, Rebecca Mister et al.|New England Journal of Medicine|2003
Cited by 625Open Access

BACKGROUND: The effect of the use of coronary-artery bypass surgery without cardiopulmonary bypass and cardiac arrest ("off pump") on graft patency remains uncertain. We undertook a prospective, randomized, controlled study to compare graft-patency rates and clinical outcomes in off-pump surgery with conventional, "on-pump" surgery. METHODS: We randomly assigned 50 patients to undergo on-pump coronary-artery bypass grafting and 54 to undergo off-pump surgery. Surgical and anesthetic techniques were standardized for both groups. Clinical outcomes and troponin T levels were measured. Three months later, the patients underwent coronary angiography, including quantitative analysis. RESULTS: The mean age of the patients was 63 years, and 87 percent were men. The on-pump group received a mean of 3.4 grafts, and the off-pump group 3.1 (P=0.41). There were no deaths. There was no significant difference in the median postoperative length of stay between the two groups (seven days in each group). The area under the curve of troponin T levels was higher during the first 72 hours in the on-pump group than in the off-pump group (30.96 hr x microg per liter vs. 19.33 hr x microg per liter, P=0.02). At three months, 127 of 130 grafts were patent in the on-pump group (98 percent), as compared with 114 of 130 in the off-pump group (88 percent, P=0.002). The patency rate was higher for all graft territories in the on-pump group than in the off-pump group. CONCLUSIONS: In this randomized study, off-pump coronary surgery was as safe as on-pump surgery and caused less myocardial damage. However, the graft-patency rate was lower at three months in the off-pump group than in the on-pump group, and this difference has implications with respect to the long-term outcome.

Monotone Instrumental Variables with an Application to the Returns to Schooling
Charles F. Manski, John Pepper|National Bureau of Economic Research|1998
Cited by 455Open Access

FOR FIFTY YEARS ECONOMETRIC ANALYSES of treatment response have made extensive use of instrumental variable (IV) assumptions holding that mean response is constant across specified subpopulations of a population of interest.2 Yet the credibility of mean independence conditions and other IV assumptions has often been a matter of considerable disagreement, with much debate about whether some covariate is or is not a valid instrument in an application of interest. There is therefore good reason to consider weaker but more credible assumptions. To this end, we introduce monotone instlumental variable (MIV) assumptions holding that mean response varies weakly monotonically across specified subpopulations. We study the identifying power of these MIV assumptions and give an empirical application. The findings reported here add to the literature developing nonparametric bounds on treatment effects.3 This paper uses the same formal setup as Manski (1997). There is a probability space (J, X2, P) of individuals. Each member j of population J has observable covariates xi E X and a response function yj( ): T -> Y mapping the mutually exclusive and exhaustive treatments t E T into outcomes yj(t) E Y. Person j has a realized treatment zj E T and a realized outcome y 1 -y(zi), both of which are observable. The latent outcomes yj(t),

Effect of Lung-Volume–Reduction Surgery in Patients with Severe Emphysema
Duncan M. Geddes, Michael Davies, Hiroshi Koyama et al.|New England Journal of Medicine|2000
Cited by 400Open Access

BACKGROUND: Although many patients with severe emphysema have undergone lung-volume-reduction surgery, the benefits are uncertain. We conducted a randomized, controlled trial of the surgery in patients with emphysema. Patients with isolated bullae were excluded because such patients are known to improve after bullectomy. METHODS: Potentially eligible patients were given intensive medical treatment and completed a smoking-cessation program and a six-week outpatient rehabilitation program before random assignment to surgery or continued medical treatment. After 15 patients had been randomized, the entry criteria were modified to exclude patients with a carbon monoxide gas-transfer value less than 30 percent of the predicted value or a shuttle-walking distance of less than 150 m, because of the deaths of 5 such patients (3 treated surgically and 2 treated medically). RESULTS: Of the 174 subjects who were initially assessed, 24 were randomly assigned to continued medical treatment and 24 to surgery. At base line in both groups, the median forced expiratory volume in one second (FEV1) was 0.75 liter, and the median shuttle-walking distance was 215 m. Five patients in the surgical group (21 percent) and three patients in the medical group (12 percent) died (P=0.43). After six months, the median FEV1 had increased by 70 ml in the surgical group and decreased by 80 ml in the medical group (P=0.02). The median shuttle-walking distance increased by 50 m in the surgical group and decreased by 20 m in the medical group (P=0.02). There were similar changes on a quality-of-life scale and similar changes at 12 months of follow-up. Five of the 19 surviving patients in the surgical group had no benefit from the treatment. CONCLUSIONS: In selected patients with severe emphysema, lung-volume-reduction surgery can improve FEV1, walking distance, and quality of life. Whether it reduces mortality is uncertain.